Stay updated on VX-880 in Type 1 Diabetes: Safety Clinical Trial
Sign up to get notified when there's something new on the VX-880 in Type 1 Diabetes: Safety Clinical Trial page.

Latest updates to the VX-880 in Type 1 Diabetes: Safety Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed study information regarding VX-880 for Type 1 diabetes and the revision number has been updated to v2.15.0.SummaryDifference10%
- Check29 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to March 5, 2025.SummaryDifference0.4%
- Check59 days agoChange DetectedThe study has increased its number of locations from 24 to 25, and a specific location in San Francisco, California, has been added. Additionally, the date of the study has been updated to March 2025.SummaryDifference2%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check87 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference2%
Stay in the know with updates to VX-880 in Type 1 Diabetes: Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VX-880 in Type 1 Diabetes: Safety Clinical Trial page.